Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446823 · ClinicalTrials.gov registry record · NA
Effectiveness of XCell on Autolytic Debridement of Venous Ulcers
A NA study of Venous Ulcer, sponsored by Xylos Corporation.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT00446823: Completed NA study of Venous Ulcer, sponsored by Xylos Corporation.
NCT00446823 is a NA study of Venous Ulcer that has completed, run by Xylos Corporation. The registered enrollment target is 50 participants, below the 155-participant average among 11 other Venous Ulcer trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00446823, a NA study of Venous Ulcer, has completed, sponsored by Xylos Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial is designed to evaluate the effect of XCell cellulose wound dressing for its ability to naturally (autolytically) remove nonviable tissue and create a healthy vascular wound bed. Results will compare venous ulcers treated with Xylos XCell cellulose dressing plus standard care to those treated with standard care alone. The hypothesis is that XCell will demonstrate more autolytic debridement than the standard of care.
Conditions Studied
Interventions
- DEVICE XCell cellulose wound dressing
- DEVICE Impregnated gauze dressing
Study Locations (3)
Massachusetts
- Boston University School of Medicine - Boston
New York
- University Wound Care Center - The Bronx
Pennsylvania
- Etris Associates - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-06 |
| Est. Completion | 2003-12 |
| Phase | NA |
What the finished NCT00446823 record still lists
NCT00446823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 155-participant average among 11 other Venous Ulcer trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Venous Ulcer appearing as the primary indexed condition, and to 2 interventions - of which XCell cellulose wound dressing is the first listed.
NCT00446823 reports a single indexed study location in Massachusetts, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00446823 about?
NCT00446823 is a clinical study titled "Effectiveness of XCell on Autolytic Debridement of Venous Ulcers". This clinical trial is designed to evaluate the effect of XCell cellulose wound dressing for its ability to naturally (autolytically) remove nonviable tissue and create a healthy vascular wound bed. Results will compare venous ulcers treated with Xylos XCell cellulose dressing plus standard care to ...
What is the current status of trial NCT00446823?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-06. Estimated completion is 2003-12.
What conditions does trial NCT00446823 study?
This clinical trial studies the following conditions: Venous Ulcer.
What interventions are being tested in trial NCT00446823?
The interventions under investigation include: XCell cellulose wound dressing (DEVICE), Impregnated gauze dressing (DEVICE).
Who is sponsoring clinical trial NCT00446823?
This trial is sponsored by Xylos Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00446823 being conducted?
This trial has 3 study locations across Massachusetts, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00446823's enrollment target sits among peer trials
50 9th of 11 higher than 2 of 11 other Venous Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
RECRUITING · NA
-
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)
COMPLETED · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Evaluating the Durability of Closure for Venous Leg Ulcers
RECRUITING
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia